ADMINISTRATIVE

该中心的领导设想建立一个主要的和永久的研究中心，专注于肺癌的差异。该中心将利用跨学科研究人员的研究活动，重点是了解和解决SES和种族/民族对肺癌连续体差异的共同贡献，重点是预防和治疗，以及奠定基础，以更好地了解遗传因素可能导致肺癌社会差异的程度。行政和领导核心（ALC）的使命是为肺癌差异中心（LCDC）提供科学，跨学科和行政领导。LCDC将位于哈佛公共卫生学院（HSPH），该学院与被称为Dana-Farber/哈佛综合癌症中心（DF/HCC）的基质癌症中心非常接近。DF/HCC是由六个哈佛机构组成的联盟：丹娜-法伯癌症研究所（DFCI）、哈佛公共卫生学院（HSPH）、哈佛医学院（HMS）、布里格姆妇女医院（BWH）、马萨诸塞州综合医院（MGH）和贝斯以色列女执事医院。该中心的主要调查员至少隶属于联邦区/总部合同委员会的一个机构。由于其重点是尖端研究，伙伴关系，培训和职业发展，LCDC人口健康和健康差异中心（CPHHD）将成为下一代健康差异研究人员的“孵化器”，特别是肺癌差异。提出的工作是DF/HCC正在进行的合作的结果，为启动和维持不同学科和疾病项目之间的合作提供了一个最佳平台。

The Center leadership envisions establishing a premier and permanent center for research focused on lung cancer disparities. The Center will draw on the research activities of a cadre of interdisciplinary investigators focused on understanding and addressing the joint contribution of SES and race/ethnicity to disparities across the lung cancer continuum, with an emphasis on prevention and treatment, as well as, laying a foundation to better understand the extent to which genetic factors may contribute to social disparities in lung cancer. The mission of the Administrative and Leadership Core (ALC) is to provide scientific, interdisciplinary and administrative leadership to the Lung Cancer Disparities Center (LCDC). The LCDC will be located at the Harvard School of Public Health (HSPH), which is physically in close proximity to the matrix cancer center known as the Dana-Farber/Harvard Comprehensive Cancer Center (DF/HCC). DF/HCC is a consortium of six Harvard institutions: the Dana-Farber Cancer Institute (DFCI), the Harvard School of Public Health (HSPH), the Harvard Medical School (HMS), and the Brigham and Woman's Hospital (BWH), Massachusetts General (MGH) and Beth Israel Deaconess Hospitals. The key investigators of the LCDC are affiliated with at least one of the DF/HCC institutions. With its emphasis on cutting-edge research, partnership, training and career development, the LCDC Center for Population Health and Health Disparities (CPHHD) will be an "incubator" for the next generation of researchers on health disparities in general and lung cancer disparities in particular. The work proposed is the result of on-going collaborations across DF/HCC which provide an optimal platform to initiate and sustain collaboration between different discipline and disease programs.